Generic Drug Competition Hearing Planned For Senate Commerce Cmte.
This article was originally published in The Tan Sheet
Executive Summary
The Senate Commerce Committee is tentatively planning to hold a hearing on anticompetitive practices affecting generic drug marketing in April or May
You may also be interested in...
Generic Reform Hearings Set In Senate, But McCain/Schumer Lacks Vehicle
Sen. Edward Kennedy (D-Mass.) has committed to generic drug reform hearings in the Health Committee this spring, Capitol Hill staffer Missy Rohrbach told the Generic Pharmaceutical Association annual meeting in Coral Gables, Fla. April 9
McCain/Schumer Generic Drug Bill Would End 30-Month Stay Of Approval
The revised McCain/Schumer generic drug bill eliminates the automatic stay of approval under current patent challenge procedures.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC